Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2026-02-22 @ 4:51 PM
Study NCT ID:
NCT02618512
Status:
TERMINATED
Last Update Posted:
2018-04-17
First Post:
2015-10-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Open Label Study in Previously Studied, SBC-103 Treatment Naïve MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-15
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-18
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-21
First Submit QC Date:
None
Study First Post Date:
2015-12-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-16
Results First Submit QC Date:
None
Results First Post Date:
2018-04-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-19
Last Update Post Date:
2018-04-17
Last Update Post Date Type:
ACTUAL